Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
experimental research complementing our activities in atomic/molecular/optical physics, quantum information science and technology, quantum photonics, precision measurement, nuclear and particle physics
-
engineering. · Gene-expression and regulatory studies. · Transcriptomic and other genomic approaches for defining downstream consequences of genetic perturbation. · Mechanistic
-
for collaborative, interdisciplinary research. The university is making significant investments in research, including the launch of two new institutes: the Convergent Bioscience and Technology Institute (CBATI) and
-
of Informatics, Computing, and Engineering, visit: https://luddy.iu.edu/ Basic Qualifications Minimum Qualifications: Applicants should possess a PhD in computer science (or a related field) and be committed
-
, and Engineering, visit: https://luddy.indiana.edu/ Basic Qualifications Minimum Qualifications: Candidates must hold a Ph.D. in computer science, informatics, engineering, or a related field from an
-
and academic units, offering degrees in fields such as business, engineering, health sciences, and the arts. A major highlight is its world-renowned Life Sciences campus, one of the largest in
-
reasonable cost of living, Bloomington offers much to all. For more information about the Luddy School of Informatics, Computing, and Engineering, visit: https://luddy.indiana.edu/ Basic Qualifications Minimum
-
Open Rank (Lecturer Track) in Cybersecurity for Cyber-Physical Systems and Founding Program Director
-technology incident response, security architecture, verification and validation, and system resilience. The program is intended to serve advanced manufacturing, connected products, automotive and engine
-
engineering techniques to address fundamental challenges in synthetic chemistry and biocatalysis. The successful applicant will use a deep understanding of organic and organometallic chemistry, combined with
-
with hearing loss, rapid generation of somatic CRISPR-based models, characterization of genetically engineered disease models, and development of in vivo approaches for manipulating gene activity within